Association of Long ATXN2 CAG Repeat Sizes With Increased Risk of Amyotrophic Lateral Sclerosis

被引:0
作者
Daoud, Hussein [4 ]
Belzil, Veronique [4 ]
Martins, Sandra [4 ,6 ]
Sabbagh, Mike [4 ]
Provencher, Pierre [5 ]
Lacomblez, Lucette [7 ]
Meininger, Vincent [7 ]
Camu, William [8 ]
Dupre, Nicolas [5 ]
Dion, Patrick A. [1 ,4 ]
Rouleau, Guy A. [2 ,3 ,4 ]
机构
[1] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Ville De Quebec, PQ, Canada
[2] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Ville De Quebec, PQ, Canada
[3] Univ Montreal, Dept Pediat & Biochem, Ville De Quebec, PQ, Canada
[4] Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Ville de Quebec, PQ, Canada
[5] Univ Quebec, Fac Med, Univ Laval, Ctr Hosp,Enfant Jesus Hosp, Ville de Quebec, PQ, Canada
[6] Univ Porto, Inst Mol Pathol & Immunol, Oporto, Portugal
[7] Hop La Pitie Salpetriere, Ctr Reference Malad Rares Sclerose Laterale Amyot, Paris, France
[8] Inst Biol, Unite Neurol Comportementale & Degenerat, Montpellier, France
基金
加拿大健康研究院;
关键词
SPINOCEREBELLAR ATAXIA TYPE-2; MUTATIONS; GENE; EXPANSION; CLONING; TDP-43;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To analyze the ataxin 2 (ATXN2) CAG repeat size in a cohort of patients with amyotrophic lateral sclerosis (ALS) and healthy controls. Large (CAG)(n) alleles of the ATXN2 gene (27-33 repeats) were recently reported to be associated with an increased risk of ALS. Design: Case-control study. Setting: France and Quebec, Canada. Participants: A total of 556 case patients with ALS and 471 healthy controls; both groups of participants are of French or French-Canadian origin. Results: We observed a significant association between ATXN2 high-length alleles (>= 29 CAG repeats) and ALS in French and French-Canadian ALS populations. Furthermore, we identified spinocerebellar ataxia type 2-pathogenic polyglutamine expansions (>= 32 CAG repeats) in both familial and sporadic ALS cases. Conclusions: Altogether, our findings support ATXN2 high-length repeats as a risk factor for ALS and further indicate a genetic link between spinocerebellar ataxia type 2 and ALS.
引用
收藏
页码:739 / 742
页数:4
相关论文
共 50 条
  • [21] APOE ε4 allele is associated with an increased risk of bulbar-onset amyotrophic lateral sclerosis in men
    Praline, J.
    Blasco, H.
    Vourc'h, P.
    Garrigue, M. -A.
    Gordon, P. H.
    Camu, W.
    Corcia, P.
    Andres, C. R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (08) : 1046 - 1052
  • [22] OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia
    Farhan, Sali M. K.
    Gendron, Tania F.
    Petrucelli, Leonard
    Hegele, Robert A.
    Strong, Michael J.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2018, 177 (01) : 75 - 85
  • [23] Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat
    Jones, Ashley R.
    Woollacott, Ione
    Shatunov, Aleksey
    Cooper-Knock, Johnathan
    Buchman, Vladimir
    Sproviero, William
    Smith, Bradley
    Scott, Kirsten M.
    Balendra, Rubika
    Abel, Olubunmi
    McGuffin, Peter
    Ellis, Catherine M.
    Shaw, Pamela J.
    Morrison, Karen E.
    Farmer, Anne
    Lewis, Cathryn M.
    Leigh, P. Nigel
    Shaw, Christopher E.
    Powell, John F.
    Al-Chalabi, Ammar
    [J]. NEUROBIOLOGY OF AGING, 2013, 34 (09) : 2234.e1 - 2234.e7
  • [24] Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions
    Highley, J. R.
    Pons, A. Lorente
    Cooper-Knock, J.
    Wharton, S. B.
    Ince, P. G.
    Shaw, P. J.
    Wood, J.
    Kirby, J.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (04) : 377 - 389
  • [25] Association studies indicate that protein disulfide isomerase is a risk factor in amyotrophic lateral sclerosis
    Kwok, Chun Tak
    Morris, Alex G.
    Frampton, Jenny
    Smith, Bradley
    Shaw, Christopher E.
    de Belleroche, Jackie
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2013, 58 : 81 - 86
  • [26] Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis
    Manini, Arianna
    Casiraghi, Valeria
    Brusati, Alberto
    Maranzano, Alessio
    Gentile, Francesco
    Colombo, Eleonora
    Bonetti, Ruggero
    Peverelli, Silvia
    Invernizzi, Sabrina
    Gentilini, Davide
    Messina, Stefano
    Verde, Federico
    Poletti, Barbara
    Fogh, Isabella
    Morelli, Claudia
    Silani, Vincenzo
    Ratti, Antonia
    Ticozzi, Nicola
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [27] Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype
    Theunissen, Frances
    Anderton, Ryan S.
    Mastaglia, Frank L.
    Flynn, Loren L.
    Winter, Samantha J.
    James, Ian
    Bedlack, Richard
    Hodgetts, Stuart
    Fletcher, Sue
    Wilton, Steve D.
    Laing, Nigel G.
    MacShane, Mandi
    Needham, Merrilee
    Saunders, Ann
    Mackay-Sim, Alan
    Melamed, Ze'ev
    Ravits, John
    Cleveland, Don W.
    Akkari, P. Anthony
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [28] The Association between C9orf72 Repeats and Risk of Alzheimer's Disease and Amyotrophic Lateral Sclerosis: A Meta-Analysis
    Shu, Li
    Sun, Qiying
    Zhang, Yuan
    Xu, Qian
    Guo, Jifeng
    Yan, Xinxiang
    Tang, Beisha
    [J]. PARKINSONS DISEASE, 2016, 2016
  • [29] Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?
    van den Heuvel, Dianne M. A.
    Harschnitz, Oliver
    van den Berg, Leonard H.
    Pasterkamp, R. Jeroen
    [J]. TRENDS IN MOLECULAR MEDICINE, 2014, 20 (01) : 25 - 35
  • [30] Meta-analysis of the association betweenCHCHD10Pro34Ser variant and the risk of amyotrophic lateral sclerosis
    Yang, Baiyuan
    Yang, Chenghui
    Ren, Junwei
    Zhong, Chengqing
    Liu, Keting
    Zhao, Liusha
    Li, Li
    Wang, Han
    Zhu, Mingling
    Lin, Zhenfang
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (02) : 625 - 631